Opportunity
Simpler Grants.gov #PAR-27-098
NIH SBIR/STTR Commercialization Readiness Pilot (CRP) Program Funding Opportunity
Buyer
National Institutes of Health
Posted
October 04, 2023
Respond By
September 05, 2026
Identifier
PAR-27-098
NAICS
541715
The National Institutes of Health (NIH) is preparing to release a funding opportunity for small businesses through the SBIR/STTR Commercialization Readiness Pilot (CRP) Program. - Government Buyer: - National Institutes of Health (NIH), including multiple Institutes and Centers - NIH SEED (Small business Education and Entrepreneurial Development) office as the contact point - Program Focus: - Supports U.S. small business concerns in advancing SBIR and STTR Phase II and IIB projects toward commercialization - Provides funding for technical assistance and later-stage R&D activities - Independent replication - IND-enabling studies - Clinical studies - Manufacturing support - Regulatory assistance - Eligibility and Requirements: - Open only to U.S. small businesses as defined by the SBA - No cost sharing or matching required - Solicitation is contingent on SBIR program reauthorization - Products/Services: - No specific products, OEMs, or part numbers are listed, as this is a grant for commercialization activities - Notable Details: - Designed to bridge the gap between research and market readiness for SBIR/STTR awardees - Emphasis on technical and regulatory support for commercialization
Description
The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications from small business concerns for the Commercialization Readiness Pilot (CRP) program. The program aims to facilitate the transition of SBIR and STTR Phase II and IIB projects to commercialization by providing support for technical assistance and later-stage research and development, including independent replication, IND-enabling studies, clinical studies, manufacturing, and regulatory assistance. Applications are not currently being solicited; publication depends on reauthorization of the SBIR program. Recipients with active Phase II or IIB SBIR/STTR awards within the last 36 months are encouraged to consider applying.